KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Payables (2016 - 2025)

Historic Payables for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $122.3 million.

  • Idexx Laboratories' Payables rose 1054.4% to $122.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.3 million, marking a year-over-year increase of 1054.4%. This contributed to the annual value of $114.2 million for FY2024, which is 322.48% up from last year.
  • Idexx Laboratories' Payables amounted to $122.3 million in Q3 2025, which was up 1054.4% from $116.6 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Payables ranged from a high of $127.3 million in Q2 2022 and a low of $86.7 million during Q3 2021
  • For the 5-year period, Idexx Laboratories' Payables averaged around $111.5 million, with its median value being $114.2 million (2024).
  • As far as peak fluctuations go, Idexx Laboratories' Payables skyrocketed by 5577.13% in 2021, and later tumbled by 1539.97% in 2023.
  • Quarter analysis of 5 years shows Idexx Laboratories' Payables stood at $116.1 million in 2021, then dropped by 5.1% to $110.2 million in 2022, then rose by 0.38% to $110.6 million in 2023, then grew by 3.22% to $114.2 million in 2024, then increased by 7.05% to $122.3 million in 2025.
  • Its Payables stands at $122.3 million for Q3 2025, versus $116.6 million for Q2 2025 and $120.1 million for Q1 2025.